PureTech News

Press Releases
ALL >
Press Release - 2024-10-21
Seaport
PureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round
Press Release - 2024-10-09
Internal Program - LYT-100
PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual Meeting
Press Release - 2024-10-01
Internal Program - LYT-100
PureTech to Present at CHEST 2024 Annual Meeting
Publications
ALL >
Publications 2024-03-04
Validating the efficacy and value proposition of mental fitness vocal biomarkers in a psychiatric population: prospective cohort study
Publications 2023-04-15
VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection
Publications 2022-04-13
Cell Host & Microbe: Colonization of the live biotherapeutic product VE303 and modulation of the microbiota and metabolites in healthy volunteers

@PureTechH